Abstract:The antiepileptic effects of the electrical stimulation therapies developed for patients with intractable epilepsies depend critically on the stimulation parameters, including the pulse duration, current, and frequency. Consequently, optimization of such therapies requires many animals for testing each of the stimulation parameters alone or in combination, which is costly and time consuming. This drawback could be reduced by testing several stimulation paradigms in each animal, but this requires an animal model of long-lasting seizures allowing such repetitive tests. This study was performed to validate such a model of long-lasting seizures. The present analysis was performed on electrocorticogram and intracortical signals collected from the somatosensory cortex of 11 Sprague Dawley rats. A protocol of controlled intravenous infusion of pentylenetetrazol (PTZ) was developed to induce spikeand-wave (SW) seizures and maintain stable those seizures for the whole experimental time. SW discharges were induced and maintained stable for 2 h in all rats through a two-stage infusion of PTZ. During the first stage, the SW discharges were induced by 2.5 min infusion of 10 mg/kg/ min PTZ. During the second stage, the SW discharges were maintained at a stable level of frequency and power for 2 h via a 0.21 mg/kg/min PTZ infusion rate. The proposed animal model of seizures is characterized by SW discharges which remain stable for 2 h. This 2-h long time interval allows repetitive tests with different stimulation parameters in each animal, which may lead to a significant reduction of the number of animals necessary for optimizing electrical stimulation therapies developed to inhibit seizures. Key Words: Pentylenetetrazol-Spike-andwave-Seizures-Model.Although many animal models of seizures have been developed to date, establishing new such models of seizures is currently in focus (1-3) as seizure models that are more suitable for basic research purposes or for testing new antiepileptic therapies are still needed (4). For example, efforts are currently made for developing electrical stimulation therapies for patients with drug-resistant epilepsies. As studies have shown, the antiepileptic effects of such therapies depend critically on the stimulation parameters, such as the duration, current, and frequency of the applied electrical pulses (5-7). Consequently, optimization of these therapies requires many animals for testing the stimulation parameters alone or in the many possible combinations, which is costly and time consuming. This drawback could be minimized by reducing the number of animals necessary for performing such tests, which would also comply with the present ethical demands related to animal studies (8,9). One way to achieve this objective is by developing animal models of longlasting seizures to allow repetitive testing of several stimulation paradigms in each animal. However epilepsy seizures are typically transient episodes (10-12) and, therefore, developing models of longlasting seizures requires method...